Why the study?
Does combination chemotherapy (CYVADIC or CYVADACT) induce remission and prolong survival in adults with widespread neuroblastoma?
Population
6 adult patients (>16 years of age) with widespread neuroblastoma diagnosed between 1974 and 1976.
Design
Case_series
Follow-up
median >11 months
Authors
Loading...
May support remission in rare adult neuroblastoma cases; hypothesis-generating and requires prospective trials.
Does combination chemotherapy (CYVADIC or CYVADACT) induce remission and prolong survival in adults with widespread neuroblastoma?
Combination chemotherapy (CYVADIC or CYVADACT) is effective in achieving remission and prolonging survival in adults with widespread neuroblastoma.
Dosik et al. (1978) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: